These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8904143)
1. Pseudomonas spp. and antibiotics in exacerbation of chronic obstructive pulmonary disease (COPD). Beghi G; Pasargiklian I; Mascheroni E; Boilini G; Scarazatti E; Lusco G J Chemother; 1995 Nov; 7 Suppl 4():163-4. PubMed ID: 8904143 [No Abstract] [Full Text] [Related]
2. [Use of new antibiotics in the treatment of Pseudomonas infections. I. In vitro tests]. Pérez Ureña MT; Iriarte MT; Fernández P Rev Clin Esp; 1969 May; 113(3):235-40. PubMed ID: 5348710 [No Abstract] [Full Text] [Related]
3. The role of infection in acute exacerbations of chronic obstructive pulmonary disease. Hillberg RE Am J Manag Care; 2000 May; 6(8 Suppl):S427-36. PubMed ID: 10977482 [TBL] [Abstract][Full Text] [Related]
4. [Pseudomonas pyocyanea: in-vitro sensitivity to antibiotics]. Cucchiara E G Mal Infett Parassit; 1971 Nov; 23(11):1045-7. PubMed ID: 5150979 [No Abstract] [Full Text] [Related]
5. [Pulmonary Pseudomonas infections]. Yu GH; Yuan JP; Zhong NS Zhonghua Nei Ke Za Zhi; 1990 Feb; 29(2):94-7, 126. PubMed ID: 2209236 [TBL] [Abstract][Full Text] [Related]
6. Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp. Fodor E; Hajdú E; Nagy E Int J Antimicrob Agents; 2005 Feb; 25(2):183-4. PubMed ID: 15664494 [No Abstract] [Full Text] [Related]
7. In vitro antibacterial activity of aminoglycoside antibiotics against Pseudomonas strains. Panse MV; Nair KR Hindustan Antibiot Bull; 1981; 23():30-2. PubMed ID: 7309552 [No Abstract] [Full Text] [Related]
8. [Chronic obstructive respiratory tract diseases: standards and trends of antibiotic therapy]. Feist H; Armbruster C; Kapfhammer G; Vetter N; Drlicek M; Hackl H Prax Klin Pneumol; 1988 Jul; 42(7):529-32. PubMed ID: 3186652 [No Abstract] [Full Text] [Related]
9. [The relationship between different serological types of Pseudomonas aeruginosa strain in lower respiratory tract and its clinical significance]. He G; Li H; Xu H Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):584-7. PubMed ID: 11477871 [TBL] [Abstract][Full Text] [Related]
17. Study of the incidence of Pseudomonas in gangrenous lesions and its sensitivity to antibiotics and to chemoterapics. Brenciaglia MI; Cipriani P; Dainelli B; Mancini C Antibiotica; 1977 Mar; 14(1):47-57. PubMed ID: 879717 [No Abstract] [Full Text] [Related]
18. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease]. Cavassini M; Calandra T; Bridevaux PO Rev Med Suisse; 2007 Apr; 3(106):939-42. PubMed ID: 17575969 [TBL] [Abstract][Full Text] [Related]
19. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa. Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093 [No Abstract] [Full Text] [Related]
20. [Antibiotic therapy of infections caused by Proteus and Pseudomonas pyocyanea]. Chernomordik AB Klin Med (Mosk); 1972 Nov; 50(11):106-9. PubMed ID: 4666690 [No Abstract] [Full Text] [Related] [Next] [New Search]